Compare CVLG & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVLG | KURA |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.1M | 744.0M |
| IPO Year | 1996 | 2015 |
| Metric | CVLG | KURA |
|---|---|---|
| Price | $27.35 | $8.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $25.88 |
| AVG Volume (30 Days) | 105.2K | ★ 1.3M |
| Earning Date | 04-22-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $705,007,000.00 | $67,482,000.00 |
| Revenue This Year | $7.17 | $62.31 |
| Revenue Next Year | $7.53 | $58.09 |
| P/E Ratio | $98.38 | ★ N/A |
| Revenue Growth | 5.12 | ★ 25.24 |
| 52 Week Low | $17.46 | $5.41 |
| 52 Week High | $30.43 | $12.49 |
| Indicator | CVLG | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 49.41 |
| Support Level | $26.45 | $7.99 |
| Resistance Level | $30.33 | $10.50 |
| Average True Range (ATR) | 1.05 | 0.39 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 78.21 | 35.51 |
Covenant Logistics Group Inc together with its wholly-owned subsidiaries, offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight, and Warehousing. The expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. The Managed Freight segment includes brokerage services and TMS. The warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.